Supplementary Figure 4 from Unique and Novel Urinary Metabolomic Features in Malignant versus Benign Adrenal Neoplasms

(A) MS-MS confirmation of identity of creatine riboside in comparison to commercial available and synthesized standards. (B) MS-MS confirmation of identity of L-tryptophan in comparison to commercial available and synthesized standards. (C) MS-MS confirmation of identity of Nε, Nε, Nε-trimethyllysine in comparison to commercial available and synthesized standards. (D) MS-MS confirmation of identity of 3-methylhistidine in comparison to commercial available and synthesized standards.